Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


20.06.2022

1 Am J Pathol
1 Biochem Biophys Res Commun
3 BMC Cancer
2 BMC Gastroenterol
1 Cancer Res
7 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
1 Gastroenterology
1 Gut
4 Hepatology
1 J Hepatol
2 J Pediatr Surg
2 Oncogene
4 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. PHAM L, Kyritsi K, Zhou T, Ceci L, et al
    The Functional Roles of Immune Cells in Primary Liver Cancer.
    Am J Pathol. 2022;192:826-836.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. HUANG L, He X, Peng W, He X, et al
    Hyperuricemia induces liver injury by upregulating HIF-1alpha and inhibiting arginine biosynthesis pathway in mouse liver and human L02 hepatocytes.
    Biochem Biophys Res Commun. 2022;617.
    PubMed         Abstract available


    BMC Cancer

  3. GEN S, Tanaka I, Morise M, Koyama J, et al
    Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis.
    BMC Cancer. 2022;22:654.
    PubMed         Abstract available

  4. WANG J, Ling S, Ni J, Wan Y, et al
    Novel gammadelta T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma.
    BMC Cancer. 2022;22:638.
    PubMed         Abstract available

  5. DENG S, Jiang Z, Cao Y, Gu J, et al
    Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study.
    BMC Cancer. 2022;22:643.
    PubMed         Abstract available


    BMC Gastroenterol

  6. LIANG Y, Zhang Z, Dai Z, Cao R, et al
    Comparative study of indocyanine green (ICG)-R15 and Albumin-Indocyanine Green Evaluation (ALICE) grading system in the prediction of posthepatectomy liver failure and postoperative mortality in patients with hepatic alveolar echinococcosis.
    BMC Gastroenterol. 2022;22:297.
    PubMed         Abstract available

  7. ANANCHUENSOOK P, Sriphoosanaphan S, Suksawatamnauy S, Siripon N, et al
    Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    BMC Gastroenterol. 2022;22:295.
    PubMed         Abstract available


    Cancer Res

  8. MAKINO Y, Hikita H, Fukumoto K, Sung JH, et al
    Constitutive activation of the tumor suppressor p53 in hepatocytes paradoxically promotes non-cell autonomous liver carcinogenesis.
    Cancer Res. 2022 Jun 13. pii: 704882. doi: 10.1158/0008-5472.CAN-21-4390.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  9. ZHAO Y, Zhang C, Zhang Y, Bo C, et al
    Effects of image-guided adaptive radiotherapy combined with hepatic artery chemoembolization in primary liver cancer patients.
    Clin Res Hepatol Gastroenterol. 2022;46:101889.
    PubMed         Abstract available

  10. YOU Y, Hu S
    Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101891.
    PubMed         Abstract available

  11. TRIPON S, Bilbault P, Fabacher T, Lefebvre N, et al
    Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
    Clin Res Hepatol Gastroenterol. 2022;46:101894.
    PubMed         Abstract available

  12. BOULOUTA A, Aggeletopoulou I, Kanaloupitis S, Tsounis EP, et al
    The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience.
    Clin Res Hepatol Gastroenterol. 2022;46:101896.
    PubMed         Abstract available

  13. SHI Q, Liu J, Li T, Zhou C, et al
    Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101893.
    PubMed         Abstract available

  14. ELGENIDY A, Afifi AM, Awad AK, Jalal PK, et al
    Utility of serum angiopoietin-2 as diagnostic marker of hepatocellular carcinoma: A systematic review and diagnostic test accuracy meta-analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101909.
    PubMed        

  15. MOREIRA-SILVA H, Amorim J, Santos-Silva E
    Incidental Liver Lesions in children: A practical and evidence-based approach.
    Clin Res Hepatol Gastroenterol. 2022;46:101904.
    PubMed         Abstract available


    Dig Dis Sci

  16. OHNO A, Fujimori N, Kaku T, Takamatsu Y, et al
    Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07555.
    PubMed         Abstract available

  17. DHIR V, Bale A
    EUS-Guided Hepatico-Gastrostomy: To Dilate or Not to Dilate?
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07560.
    PubMed        


    Gastroenterology

  18. DUURSMA SS, Verkade HJ, Bodewes FAJA
    Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
    Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
    PubMed        


    Gut

  19. UCHE-ANYA E, Anyane-Yeboa A, Berzin TM, Ghassemi M, et al
    Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity.
    Gut. 2022 Jun 10. pii: gutjnl-2021-326271. doi: 10.1136/gutjnl-2021-326271.
    PubMed         Abstract available


    Hepatology

  20. LI B, Yu D
    Is the intratumor steatosis a novel biomarker for predicting the efficacy of immunotherapy in hepatocellular carcinoma?
    Hepatology. 2022 Jun 15. doi: 10.1002/hep.32616.
    PubMed        

  21. XU C, Fan J, Liu D, Tuerdi A, et al
    Alpha-kinase 1 (ALPK1) Agonist, DF-006 Demonstrates Potent Efficacy in Murine and Primary Human Hepatocyte Models of Hepatitis B.
    Hepatology. 2022 Jun 14. doi: 10.1002/hep.32614.
    PubMed         Abstract available

  22. LIAO J, Yi Y, Yue X, Wu X, et al
    METTL1 is required for non-homologous end joining repair and renders hepatocellular carcinoma resistant to radiotherapy.
    Hepatology. 2022 Jun 14. doi: 10.1002/hep.32615.
    PubMed         Abstract available

  23. MA X, Chen A, Melo L, Clemente-Sanchez A, et al
    Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation.
    Hepatology. 2022 Jun 13. doi: 10.1002/hep.32604.
    PubMed         Abstract available


    J Hepatol

  24. TANG Y, Chen Y, Chen HN
    A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: considerations.
    J Hepatol. 2022 Jun 8. pii: S0168-8278(22)00354.
    PubMed        


    J Pediatr Surg

  25. XU M, Dong C, Sun C, Wang K, et al
    Management and outcome of hepatic artery thrombosis with whole-liver transplantation using donors less than one year of age.
    J Pediatr Surg. 2022 May 16. pii: S0022-3468(22)00344.
    PubMed         Abstract available

  26. UENO T, Takase K, Toyama C, Deguchi K, et al
    Clinical implications of serum autotoxin in regular follow up after pediatric living donor liver transplantation for biliary atresia.
    J Pediatr Surg. 2022 Mar 14. pii: S0022-3468(22)00207.
    PubMed         Abstract available


    Oncogene

  27. LIU Y, Ouyang L, Mao C, Chen Y, et al
    PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jun 10. pii: 10.1038/s41388-022-02370.
    PubMed         Abstract available

  28. MA XL, Zhu KY, Chen YD, Tang WG, et al
    Identification of a novel Calpain-2-SRC feed-back loop as necessity for beta-Catenin accumulation and signaling activation in hepatocellular carcinoma.
    Oncogene. 2022 Jun 13. pii: 10.1038/s41388-022-02367.
    PubMed         Abstract available


    Transplant Proc

  29. LEE S, Kim KW, Lee J, Park T, et al
    Visceral Fat Area Is an Independent Risk Factor for Overweight or Obese Nonalcoholic Fatty Liver Disease in Potential Living Liver Donors.
    Transplant Proc. 2022;54:702-705.
    PubMed         Abstract available

  30. RUF F, Schmidt KM, Pross A, Zeman F, et al
    Positive Microbiological Cultures in the Respiratory Tract of High Model for End-Stage Liver Disease (MELD) Liver Transplant Recipients With and Without Pneumonia.
    Transplant Proc. 2022 Mar 3. pii: S0041-1345(22)00097.
    PubMed         Abstract available

  31. PARK M, Park IH, Kim GS
    The Requirement of Isoflurane and Remifentanil During Liver Transplantation Using Bispectral Index and Surgical Pleth Index: An Observational Study.
    Transplant Proc. 2022 Feb 28. pii: S0041-1345(22)00096.
    PubMed         Abstract available

  32. HENDELE JB, Perkins JD, Leca N, Biggins SW, et al
    Optimizing Risk Assessment In Simultaneous Liver and Kidney Transplant: Donor and Recipient Factors Associated With Improved Outcome.
    Transplant Proc. 2022 Mar 5. pii: S0041-1345(22)00090.
    PubMed         Abstract available


    Transplantation

  33. JARASVARAPARN C, Rusch C, Stoll J, Kulkarni S, et al
    Pediatric Subjects With Cirrhosis Are Not at a Higher Risk of Bleeding or Clotting due to a Rebalanced Hemostatic System.
    Transplantation. 2021;105.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: